<DOC>
	<DOCNO>NCT02056223</DOCNO>
	<brief_summary>Current pharmacological option treat hemodynamically significant PDA ( HsPDA ) preterm infant limit non-selective cyclo-oxygenase ( COX ) inhibitor , indomethacin ibuprofen . Recently paracetamol exposure report successful closure PDA . Aim randomize double-blind control study compare efficacy safety standard PDA treatment ibuprofen versus paracetamol-experimental treatment . We hypothesize paracetamol effective ibuprofen closing PDA , perhaps ameliorate safety profile pharmacological treatment .</brief_summary>
	<brief_title>Paracetamol v Ibuprofen PDA Closure Preterm Infants .</brief_title>
	<detailed_description>The objective trial compare efficacy safety 2 therapeutic regimen PDA treatment population preterm newborns gestational age ( GA ) &lt; 31+6 week respiratory distress syndrome ( RDS ) HsPDA : - Group A : experimental bolus paracetamol 15 mg/Kg four time day three consecutive day . - Group B : standard boluses ibuprofen 10-5-5-mg/Kg/dose day three consecutive day . The primary objective study : evaluate efficacy paracetamol versus standard ibuprofen regimen , compare rate ductal closure first second course pharmacological treatment . ( PDA diagnose ECHO criterion ) The secondary objective study : evaluate safety 2 therapeutic regimen term incidence transient renal impairment , intraventricular hemorrhage ( IVH ) bleeding disorder , necrotizing enterocolitis ( NEC ) isolate bowel perforation ( without sign NEC ) , incidence sign liver toxicity .</detailed_description>
	<mesh_term>Respiratory Distress Syndrome , Newborn</mesh_term>
	<mesh_term>Respiratory Distress Syndrome , Adult</mesh_term>
	<mesh_term>Ductus Arteriosus , Patent</mesh_term>
	<mesh_term>Acetaminophen</mesh_term>
	<mesh_term>Ibuprofen</mesh_term>
	<criteria>inborn neonate preterm neonate â‰¤ 31+ 6 day week gestation newborn HsPDA parental write informed consent participation study must obtain Serum creatinine concentration great 1,5 mg/dl ( 132MMole/L ) Urine output le 1 ml/Kg/h Severe IVH ( &gt; grade II accord Volpe classification ) Clinical bleeding tendency ( revealed hematuria , blood gastric aspirate stool , blood endotracheal tube aspirate ) Necrotizing enterocolitis mark abdominal distention gastric bile residual Thrombocyte count le 50.000/mm3 Proved Sepsis Severe coagulopathy liver failure Evidence severe birth asphyxia , APGAR score 5 5 minute age and/or umbilical arterial pH &lt; 7.0 Known genetic chromosomal disorder Participation another clinical trial placebo , drug , biological , device conduct provision protocol .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>72 Hours</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Patent ductus arteriosus</keyword>
	<keyword>Preterm infant</keyword>
	<keyword>Paracetamol</keyword>
	<keyword>Ibuprofen</keyword>
</DOC>